PDE4A and psoriatic arthritis: When PDE4 inhibitors such as apremilast are introduced into the cell, the resulting increase in cAMP levels in immune cells helps to decrease the inflammation that occurs in psoriasis and psoriatic arthritis (Schafer, 2012).